<aside> 📗 You’re viewing the Free Preview Version. Upgrade to Full Access

</aside>

Femtech has a massive total addressable market across multiple billion-dollar industries such as (1) D2C and e-commerce, (2) digital health, (3) at-home test kits, and (4) employee health.

The rise of femtech has elevated equal access to healthcare and well-being for all. Women’s unique health issues are being addressed by companies like Allara Health which treats polycystic ovary syndrome (PCOS); Feminade for hormonal health, Maven Clinic for pregnancy care, and Carrot Fertility for fertility care.

Today, we’ll analyze top startups in femtech — how they are differentiated, how they tap into validated market needs & how builders & funders can capitalize on these market trends.

Top 9 Femtech Market Trends

(1) VC funding in femtech is growing:

• Globally, femtech startups raised $2.5 billion in Q4 2021 — up 3x from $750 million in 2020.
• Top categories for femtech funding: Primary care ($668 million), Pregnancy and parenthood care ($316 million), and Fertility support ($220 million).
• Femtech funding is making positive progress, however, a significant funding gap still exists–with only 7% of digital health funding going to women’s health.

(2) Rise of femtech unicorns and top funding round:

• Maven Clinic raised over $110 million Series D from investors including Oprah Winfrey. The company is now valued at more than $1 billion.
• Kindbody acquired Vios Fertility Institute, pushing the company’s valuation to over $1 billion.
• Elvie offers connected breast pumps and pelvic floor trainer devices raised $97 million Series C.
• Illumigyn, a remote gynecological screening platform closed $33M.
• Flo Health, menstruation, and fertility tracking app closed $50 million Series B.

(3) DTC femtech brands are becoming the target for acquisition:

• Modern Fertility, a digital fertility clinic was acquired by Ro for $225 million.
• Fleur Marché, CBD-based products for improving women’s sleep, sex, and energy level was acquired by Equilibria.
• Thinx, a reusable period and incontinence underwear company was acquired by Kimberly-Clark Corporation via majority stakes.